Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history shows Revision: v3.6.5 replacing v3.6.4, indicating a small maintenance update to the page’s interface. It does not change study data or outcomes.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of Revision: v3.6.3, indicating a minor version update to the page template with no apparent changes to the study data or visible content.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3, indicating a small interface update. No study record history content appears to be changed.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history now displays the latest Revision: v3.6.2 and removes Revision: v3.6.0. This updates the record's revision metadata on the page.SummaryDifference0.1%

- Check69 days agoChange DetectedA new version entry v3.6.0 was added to the study history with a note that the study is no longer looking for participants. The previous version (v3.5.5) was removed from the history.SummaryDifference0.3%

- Check76 days agoChange DetectedThe revision history now shows the latest version as v3.5.5, replacing the previous v3.5.4 in the record's metadata.SummaryDifference0.1%

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.